Trade ARMP anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Armata Pharmaceuticals, Inc. (ARMP) is trading at US$5.26, down 3.22% today as of Aug 28, 13:57 EDT. The company has a market capitalisation of US$189.63M. Over the past 52 weeks, ARMP has traded between US$2.40 and US$16.34. On Syfe you can trade ARMP with $0 commission and add it to your watchlist.
| Previous close | US$5.43 |
|---|---|
| Market cap | US$189.63M |
| 52-week range | US$2.40 – US$16.34 |
| Volume | 270.44K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
Year: 1994
Armata Pharmaceuticals Names David House as CFO; Advances Staphylococcus Aureus Treatment Candidate
Jul 20, 12:51 PM · MT Newswires
Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02
Jul 13, 11:47 AM · MT Newswires
Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday
Jun 23, 1:14 PM · MT Newswires
Armata Pharmaceuticals Receives Additional $2.5 Million in Funding From US Department of Defense
Jun 23, 11:40 AM · MT Newswires
Armata Pharmaceuticals, Inc. (ARMP) stock is trading at US$5.26, -3.22% from the previous close of US$5.43.
The market cap for Armata Pharmaceuticals, Inc. (ARMP) stock is approximately US$189.63M.
The 52-week high for Armata Pharmaceuticals, Inc. (ARMP) stock is US$16.34.
The 52-week low for Armata Pharmaceuticals, Inc. (ARMP) stock is US$2.40.
Armata Pharmaceuticals, Inc. (ARMP) does not currently pay a dividend.
Stay on top of ARMP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
